Concepedia

Author

Lidija Covic

Tufts Medical CenterORCID

Also Known As

L Covic, L. Covic, Lidija Covic

149

Publications

6K

Citations

41

H-Index

65

Concepts

All Affiliations

Tufts Medical CenterTufts UniversityMolecular Oncology (United States)Boston UniversityMount Auburn Hospital
LC

About

Lidija Covic is an author at Tufts Medical Center specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

21

2.4K

2

Natural Sciences

5

5

399

3

Biochemistry

2

2

105

4

Biomolecular Engineering

2

2

76

5

Biology

1

1

38

Lidija Covic

×

51

Publications

5.2K

Citations

38

H-Index

YearCitations

PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells

Adrienne Boire, Lidija Covic, Anika Agarwal,

Cell

2005

836

Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides

Lidija Covic, Amy L. Gresser, Joyce R. Talavera,

Proceedings of the National Academy of Sciences

2002

312

Biphasic Kinetics of Activation and Signaling for PAR1 and PAR4 Thrombin Receptors in Platelets

Lidija Covic, Amy L. Gresser, Athan Kuliopulos

Biochemistry

2000

302

Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation

Lidija Covic, Meghna V. Misra, Jehangir Badar,

Nature Medicine

2002

277

Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site

Vishal Trivedi, Adrienne Boire, Boris Tchernychev,

Cell

2009

242

'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage

Nicole C. Kaneider, Andrew J. Leger, Anika Agarwal,

Nature Immunology

2007

230

Plasmin Desensitization of the PAR1 Thrombin Receptor:  Kinetics, Sites of Truncation, and Implications for Thrombolytic Therapy

Athan Kuliopulos, Lidija Covic, Stacy K. Seeley,

Biochemistry

1999

220

Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis

Andrew J. Leger, Suzanne L. Jacques, Jehangir Badar,

Circulation

2006

215

Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis

Eric Yang, Adrienne Boire, Anika Agarwal,

Cancer Research

2009

144

Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins

Leila M. Sevigny, Ping Zhang, Andrew Bohm,

Proceedings of the National Academy of Sciences

2011

115

Page 1